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Summary The relationship between silicosis and tuberculosis is well known. Also
other mycobacteria such as Mycobacterium kansasii often occur in association with
pneumoconiosis. However, there are few reports describing an association of
M. avium-intracellulare complex (MAC) lung disease and pneumoconiosis. The
purpose of the present study is to describe clinical features of MAC respiratory
infection associated with pneumoconiosis. Eleven patients with MAC respiratory
infection associated with pneumoconiosis (all men, 6 with silicosis and 5 with
welders’ pneumoconiosis) were collected. A determination of whether or not MAC
caused pulmonary disease was made using the 1997 criteria required by the
American Thoracic Society. Radiologically, cavity formation as well as upper lung
field predominance of MAC disease were observed in 8 of 11 cases (72.7%). Two of 11
patients died of respiratory failure. Our present study clearly demonstrates that
clinical features of MAC respiratory infection associated with pneumoconiosis were
different from MAC without underlying diseases.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
The increased incidence of Mycobacterium tuber-
culosis in silicotic patients is well known.1–3 Also,
atypical mycobacterial infections appear to be
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more frequent in patients with pneumoconiosis,
especially M. kansasii disease.1,4,5 More recently,
Corbett et al. have reported that M. kansasii and
M. scrofulaceum disease are common in HIV-
negative South African gold miners and most
isolates are associated with new cavitation against
a background of silicosis or old tuberculosis scar-
ing.6–8 However, there are few reports describing
M. avium-intracellulare complex (MAC) disease
associated with pneumoconiosis.9–11 In the present
study, retrospective cases of MAC respiratory
infection in patients with pneumoconiosis were
collected and clinical features are described.
Materials and Methods
Patients
A retrospective study was performed in 11 cases of
positive sputum cultured for MAC. Patients were
collected from 1991 to 2002. The criteria for de
fining NTM pulmonary disease were those of the
American Thoracic Society (1997).12 Briefly, the
diagnosis of lung disease caused by MAC is based on
a combination of clinical, radiographic, and bacter-
iologic criteria. Minimal evaluation should include
three or more sputums for acid-fast bacteria and
efforts to exclude other confounding disorders such
as tuberculosis and lung malignancy.12 In 4 patients,
a diagnosis can be made with histological examina-
tion obtained at the operation. Both culture and
PCR methods were used to identify mycobacteria
and mycobacteria were detected in sputum in all
patients. Drug sensitivity test for MAC was per-
formed in none of these patients.
Silicosis was diagnosed by occupational history
(tunnel construction work and inhalation of silica
dust) and multiple nodules on chest radiography.
Welders’ pneumoconiosis was diagnosed by occupa-
tional history (arc welding and inhalation of
iron dust or fumes) and interstitial changes
on chest radiography. In 4 of 5 patients with
welder’s pneumoconiosis, diagnosis was confirmed
histologically by evaluating operated specimens.
Characteristics of these 11 patients are listed in
Table 1. Smoking index was calculated as follows;
number of cigarettes per day  smoking interval
(years). In our report, there were no patients who
had AIDS.
Radiological findings
Chest X-ray and computed tomography (CT) of the
chest were performed in all patients. The presence
of cavities and the distribution of lesions caused by
MAC were classified as upper lung field predomi-
nance, upper and lower lung field predominance,
and lower lung field predominance.
Results
Radiological findings of MAC respiratory infection
associated with pneumoconiosis are listed in
Table 2. Cavity formation was observed in 8 of 11
cases (72.7%). Three cases were determined
as upper and lower lung fields predominance, 8 of
11 cases were clearly demonstrated to be upper
lung fields predominance. Examples of chest
X-ray and chest CT findings are demonstrated in
Figs. 1–4 (cases 1 and 4). Chest X-ray and chest CT
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Table 1 Patient characteristics.
Case Age and sex Background Smoking index WBC %VC FEV1% PaO2 Species
1 65M Silicosis 900 6300 75.6 65.8 F M. avium
2 73M Silicosis 1000 8600 F F 78 M. avium
3 75M Silicosis 200 4900 75.1 36.8 64 M. avium
4 64M Silicosis 1400 7400 95 72.9 87.7 M. intracellulare
5 75M Silicosis 680 5800 77.7 59 78.5 M. avium
6 78M Silicosis 600 5000 107.8 79.3 91.9 M. avium
7 47M Welder’s pneumoconiosis 0 7800 92.2 72 86.1 M. avium
8 56M Welder’s pneumoconiosis 0 6000 112.7 80.3 81 MACn
9 33M Welder’s pneumoconiosis 0 7200 80.6 71.8 78.1 MAC
10 48M Welder’s pneumoconiosis 80 10900 76.8 75.1 94.7 MAC
11 59M Welder’s pneumoconiosis 1750 3000 91.9 78.8 94 M. avium
nUnclassified.
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Table 2 Radiological findings of MAC infection associated with pneumoconiosis.
Case Age and sex Cavity Predominant lesion Therapy Duration of
chemotherapy
Response to
chemotherapy
Prognosis
1 65M þ Upper EBþRFPþCAM 24 No response Alive
2 73M þ Upper EBþRFPþCAMþ SM 12 No response Dead
3 75M  Upper¼ lower None 0 F Alive
4 64M þ Upper EBþRFPþCAM 22 No response Dead
5 75M þ Upper EBþRFPþCAM 36 Good Alive
6 78M  Upper¼ lower EBþRFPþCAM 30 Good Alive
7 47M  Upper¼ lower EBþRFPþCAM 18 Good Alive
8 56M þ Upper Operation 0 F Alive
9 33M þ Upper INHþRFP-CSþ SM-Operation 12 No response Alive
10 48M þ Upper Operation-INHþRFPþ SMþCAM 12 Good Alive
11 59M þ Upper Operation-CAM 24 No response Alive
EB: ethanbutol, RFP: rifampicin, CAM: clarithromycin, CS: cycloserine, SM: streptomycin.
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Discussion
In the present study, we describe the clinical
features of MAC respiratory infection associated
with pneumoconiosis.
Previously, it had been believed that the majority
of patients with MAC pulmonary disease have
chronic underlying lung disease such as bronchiec-
tasis, chronic bronchitis and emphysema.13,14 In
these patients, the radiographic pattern may be
indistinguishable from post-primary tuberculosis,
characterized by nodules, consolidation, and cav-
ities, most often affecting the upper lobes and
superior segments of the lower lobes. Radio-
graphic patterns in patients with pneumoconiosis
demonstrated in the present study also showed
upper lung field predominance and frequent cavity
formation.
In contrast, Prince et al. have reported that
pulmonary disease caused by MAC can affect
persons without predisposing conditions, particu-
larly elderly women.13 More recently, there have
been several reports describing a strong association
between bronchiectasis with circumscribed nodules
and MAC infection in elderly women in the absence
of underlying malignancy or immune compro-
mise.15–18 This pattern is characterized by bronch-
iectasis and nodular densities, particularly
affecting the middle lobe and lingua. Therefore,
radiological findings are quite different between
MAC respiratory infection without underlying dis-
eases in mostly elderly women19–23 and MAC with
pneumoconiosis in mostly elderly men.
The incidence of mycobacterial infection is 25%
in patients with exposure to high concentrations of
silica.1 While half of the mycobacterial infections
are caused by M. tuberculosis, the other half are
caused by atypical organisms such as M. kansasii
and M. avium-intracellulare.1 There also is an
increased incidence of fungal infection in these
patients. Some of the infections are caused by
opportunistic organisms, such as Nocardia and
Cryptococcus.24 The primary cause of the increased
incidence of mycobacterial and fungal infections is
an acquired macrophage dysfunction. It has been
shown that M. tuberculosis organisms within
macrophages multiply more rapidly in the presence
of silica.25 Therefore, in patients with silicosis, the
upper lung field predominance of MAC respiratory
infection may be explained by the fact that the
distribution of nodules caused by silica inhalation is
also predominated in the upper lung fields.
In the present study, 2 patients died of respira-
tory failure despite intensive treatment. There-
fore, it seems that MAC associated with
pneumocoinosis is more difficult to treat in patients
without underlying diseases.
In conclusion, in the present report, we clearly
demonstrated clinical features of MAC respiratory
infection associated with silicosis.
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